M&A Deal Summary |
|
---|---|
Date | 2008-10-03 |
Target | Ferro Corp - Fine Chemicals Business |
Sector | Chemicals |
Buyer(s) | Novolyte Technologies |
Sellers(s) | Ferro |
Deal Type | Divestiture |
Deal Value | 66M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2008 |
Sector | Electronics |
Employees | 167 |
Novolyte Technologies is a manufacturer and supplier of specialty electrolyte materials and high performance solvents for lithium ion battery and energy storage applications.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Chemicals) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2008) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
Ferro is a global supplier of technology-based functional coatings and color solutions. Ferro supplies functional coatings for glass, metal, ceramic, and other substrates and color solutions in the form of specialty pigments and colorants for a broad range of industries and applications. Ferro products are sold into the building and construction, automotive, electronics, industrial products, household furnishings, and appliance markets. The Company's reportable segments include Functional Coatings and Color Solutions. Ferro was formed in 1919 and is based in Mayfield Heights, Ohio.
DEAL STATS | # |
---|---|
Overall | 1 of 4 |
Sector (Chemicals) | 1 of 3 |
Type (Divestiture) | 1 of 4 |
Country (United States) | 1 of 4 |
Year (2008) | 1 of 1 |
Size (of disclosed) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2008-07-21 |
Fluid Logic - Grinding Fluids Business
United States Fluid Logic - Grinding Fluids Business comprises grinding fluids used in the production of electronic components based on ceramic and quartz substrates, and advanced polishing fluids used for flat glass, precision optics, ophthalmic lenses, and specialty plastics. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-04-01 |
Pfanstiehl
Waukegan, Illinois, United States Pfanstiehl, Inc. is a provider of specialized products and services for niche pharmaceutical and biotechnological applications. Pfanstiehl develops and manufactures high-purity, low-endotoxin sugars utilized as injectable excipients and for cell culture media and protein stabilization as well as high-potency active pharmaceutical ingredients (APIs), including cytotoxic actives. Pfanstiehl was founded in 1919 and is based in Waukegan, Illinois. |
Sell | - |